O	0	13	Antiapoptotic	Antiapoptotic	JJ	B-NP
O	14	20	effect	effect	NN	I-NP
O	21	23	of	of	IN	B-PP
O	24	35	coagulation	coagulation	NN	B-NP
O	36	42	factor	factor	NN	I-NP
O	43	47	VIIa	VIIa	NN	I-NP
O	47	48	.	.	.	O

O	49	56	Binding	Binding	NN	B-NP
O	57	59	of	of	IN	B-PP
O	60	66	factor	factor	NN	B-NP
O	67	71	VIIa	VIIa	NN	I-NP
O	72	73	(	(	(	O
O	73	78	FVIIa	FVIIa	NN	B-NP
O	78	79	)	)	)	O
O	80	82	to	to	TO	B-PP
O	83	86	its	its	PRP$	B-NP
B-Cell	87	95	cellular	cellular	JJ	I-NP
O	96	104	receptor	receptor	NN	I-NP
O	105	111	tissue	tissue	NN	I-NP
O	112	118	factor	factor	NN	I-NP
O	119	120	(	(	(	O
O	120	122	TF	TF	NN	B-NP
O	122	123	)	)	)	O
O	124	127	was	be	VBD	B-VP
O	128	138	previously	previously	RB	I-VP
O	139	144	shown	show	VBN	I-VP
O	145	147	to	to	TO	I-VP
O	148	154	induce	induce	VB	I-VP
O	155	162	various	various	JJ	B-NP
B-Immaterial_anatomical_entity	163	176	intracellular	intracellular	JJ	I-NP
O	177	186	signaling	signaling	NN	I-NP
O	187	193	events	event	NNS	I-NP
O	193	194	,	,	,	O
O	195	200	which	which	WDT	B-NP
O	201	205	were	be	VBD	B-VP
O	206	213	thought	think	VBN	I-VP
O	214	216	to	to	TO	I-VP
O	217	219	be	be	VB	I-VP
O	220	231	responsible	responsible	JJ	B-ADJP
O	232	235	for	for	IN	B-PP
O	236	238	TF	TF	NN	B-NP
O	238	239	-	-	HYPH	O
O	239	247	mediated	mediate	VBN	B-NP
O	248	256	biologic	biologic	JJ	I-NP
O	257	264	effects	effect	NNS	I-NP
O	264	265	,	,	,	O
O	266	275	including	include	VBG	B-PP
O	276	288	angiogenesis	angiogenesis	NN	B-NP
O	288	289	,	,	,	O
B-Cancer	290	295	tumor	tumor	NN	B-NP
O	296	306	metastasis	metastasis	NN	I-NP
O	306	307	,	,	,	O
O	308	311	and	and	CC	O
O	312	322	restenosis	restenosis	NN	B-NP
O	322	323	.	.	.	O

O	324	326	To	To	TO	B-VP
O	327	337	understand	understand	VB	I-VP
O	338	341	the	the	DT	B-NP
O	342	352	mechanisms	mechanism	NNS	I-NP
O	353	359	behind	behind	IN	B-PP
O	360	365	these	these	DT	B-NP
O	366	375	processes	process	NNS	I-NP
O	375	376	,	,	,	O
O	377	379	we	we	PRP	B-NP
O	380	384	have	have	VBP	B-VP
O	385	393	examined	examine	VBN	I-VP
O	394	397	the	the	DT	B-NP
O	398	404	effect	effect	NN	I-NP
O	405	407	of	of	IN	B-PP
O	408	413	FVIIa	FVIIa	NN	B-NP
O	414	416	on	on	IN	B-PP
O	417	426	apoptosis	apoptosis	NN	B-NP
O	426	427	.	.	.	O

B-Organism_substance	428	433	Serum	Serum	NN	B-NP
O	434	445	deprivation	deprivation	NN	I-NP
O	445	446	-	-	HYPH	B-NP
O	446	453	induced	induce	VBN	I-NP
O	454	463	apoptosis	apoptosis	NN	I-NP
O	464	466	of	of	IN	B-PP
B-Cell	467	470	BHK	BHK	NN	B-NP
I-Cell	470	471	(	(	(	O
I-Cell	471	472	+	+	SYM	O
I-Cell	472	474	TF	TF	NN	O
I-Cell	474	475	)	)	)	O
I-Cell	476	481	cells	cell	NNS	B-NP
O	482	485	was	be	VBD	B-VP
O	486	499	characterized	characterize	VBN	I-VP
O	500	502	by	by	IN	B-PP
O	503	512	apoptotic	apoptotic	JJ	B-NP
B-Cellular_component	513	518	blebs	bleb	NNS	I-NP
O	518	519	,	,	,	O
B-Cellular_component	520	526	nuclei	nucleus	NNS	B-NP
O	527	531	with	with	IN	B-PP
B-Cellular_component	532	541	chromatin	chromatin	NN	B-NP
O	541	542	-	-	HYPH	B-NP
O	542	551	condensed	condense	VBN	I-NP
O	552	558	bodies	body	NNS	I-NP
O	558	559	,	,	,	O
O	560	563	DNA	DNA	NN	B-NP
O	564	575	degradation	degradation	NN	I-NP
O	575	576	,	,	,	O
O	577	580	and	and	CC	O
O	581	591	activation	activation	NN	B-NP
O	592	594	of	of	IN	B-PP
O	595	602	caspase	caspase	NN	B-NP
O	603	604	3	3	CD	I-NP
O	604	605	.	.	.	O

O	606	611	FVIIa	FVIIa	NN	B-NP
O	612	620	markedly	markedly	RB	B-ADVP
O	621	630	decreased	decrease	VBD	B-VP
O	631	634	the	the	DT	B-NP
O	635	641	number	number	NN	I-NP
O	642	644	of	of	IN	B-PP
B-Cell	645	650	cells	cell	NNS	B-NP
O	651	655	with	with	IN	B-PP
O	656	665	apoptotic	apoptotic	JJ	B-NP
O	666	676	morphology	morphology	NN	I-NP
O	677	680	and	and	CC	O
O	681	690	prevented	prevent	VBD	B-VP
O	691	694	the	the	DT	B-NP
O	695	698	DNA	DNA	NN	I-NP
O	699	710	degradation	degradation	NN	I-NP
O	711	713	as	as	IN	B-SBAR
O	714	722	measured	measure	VBN	B-VP
O	723	725	by	by	IN	B-PP
O	726	731	means	mean	NNS	B-NP
O	732	734	of	of	IN	B-PP
O	735	738	TdT	TdT	NN	B-NP
O	738	739	-	-	HYPH	B-NP
O	739	747	mediated	mediate	VBN	I-NP
O	748	752	dUTP	dUTP	NN	I-NP
O	753	757	nick	nick	NN	I-NP
O	758	761	end	end	NN	I-NP
O	762	770	labeling	labeling	NN	I-NP
O	771	772	(	(	(	O
O	772	777	TUNEL	TUNEL	NN	B-NP
O	777	778	)	)	)	O
O	778	779	.	.	.	O

O	780	783	The	The	DT	B-NP
O	784	797	antiapoptotic	antiapoptotic	JJ	I-NP
O	798	804	effect	effect	NN	I-NP
O	805	807	of	of	IN	B-PP
O	808	813	FVIIa	FVIIa	NN	B-NP
O	814	817	was	be	VBD	B-VP
O	818	827	confirmed	confirm	VBN	I-VP
O	828	830	by	by	IN	B-PP
O	831	834	the	the	DT	B-NP
O	835	846	observation	observation	NN	I-NP
O	847	851	that	that	IN	B-SBAR
O	852	857	FVIIa	FVIIa	NN	B-NP
O	858	868	attenuated	attenuate	VBD	B-VP
O	869	876	caspase	caspase	NN	B-NP
O	877	878	3	3	CD	I-NP
O	879	889	activation	activation	NN	I-NP
O	889	890	.	.	.	O

O	891	896	FVIIa	FVIIa	NN	B-NP
O	896	897	-	-	HYPH	O
O	897	904	induced	induce	VBN	B-NP
O	905	918	antiapoptotic	antiapoptotic	JJ	I-NP
O	919	925	effect	effect	NN	I-NP
O	926	929	was	be	VBD	B-VP
O	930	939	dependent	dependent	JJ	B-ADJP
O	940	942	on	on	IN	B-PP
O	943	946	its	its	PRP$	B-NP
O	947	958	proteolytic	proteolytic	JJ	I-NP
O	959	967	activity	activity	NN	I-NP
O	968	971	and	and	CC	I-NP
O	972	974	TF	TF	NN	I-NP
O	975	978	but	but	CC	O
O	979	990	independent	independent	JJ	B-ADJP
O	991	993	of	of	IN	B-PP
O	994	1000	factor	factor	NN	B-NP
O	1001	1003	Xa	Xa	NN	I-NP
O	1004	1007	and	and	CC	I-NP
O	1008	1016	thrombin	thrombin	NN	I-NP
O	1016	1017	.	.	.	O

O	1018	1023	FVIIa	FVIIa	NN	B-NP
O	1023	1024	-	-	HYPH	B-NP
O	1024	1031	induced	induce	VBN	I-NP
B-Cell	1032	1036	cell	cell	NN	I-NP
O	1037	1045	survival	survival	NN	I-NP
O	1046	1056	correlated	correlate	VBD	B-VP
O	1057	1061	with	with	IN	B-PP
O	1062	1065	the	the	DT	B-NP
O	1066	1076	activation	activation	NN	I-NP
O	1077	1079	of	of	IN	B-PP
O	1080	1083	Akt	Akt	NN	B-NP
O	1084	1087	and	and	CC	O
O	1088	1091	was	be	VBD	B-VP
O	1092	1101	inhibited	inhibit	VBN	I-VP
O	1102	1110	markedly	markedly	RB	B-ADVP
O	1111	1113	by	by	IN	B-PP
O	1114	1117	the	the	DT	B-NP
O	1118	1126	specific	specific	JJ	I-NP
O	1127	1130	PI3	PI3	NN	I-NP
O	1130	1131	-	-	HYPH	I-NP
O	1131	1137	kinase	kinase	NN	I-NP
O	1138	1147	inhibitor	inhibitor	NN	I-NP
O	1147	1148	,	,	,	O
O	1149	1157	LY294002	LY294002	NN	B-NP
O	1157	1158	.	.	.	O

O	1159	1167	Blocking	Block	VBG	B-VP
O	1168	1171	the	the	DT	B-NP
O	1172	1182	activation	activation	NN	I-NP
O	1183	1185	of	of	IN	B-PP
O	1186	1189	p44	p44	NN	B-NP
O	1189	1190	/	/	SYM	O
O	1190	1192	42	42	CD	B-NP
O	1193	1200	mitogen	mitogen	NN	I-NP
O	1200	1201	-	-	HYPH	O
O	1201	1210	activated	activate	VBN	B-NP
O	1211	1218	protein	protein	NN	I-NP
O	1219	1225	kinase	kinase	NN	I-NP
O	1226	1227	(	(	(	O
O	1227	1231	MAPK	MAPK	NN	B-NP
O	1231	1232	)	)	)	O
O	1233	1235	by	by	IN	B-PP
O	1236	1239	the	the	DT	B-NP
O	1240	1248	specific	specific	JJ	I-NP
O	1249	1256	mitogen	mitogen	NN	I-NP
O	1256	1257	-	-	HYPH	O
O	1257	1264	induced	induce	VBN	B-NP
O	1265	1278	extracellular	extracellular	JJ	I-NP
O	1279	1285	kinase	kinase	NN	I-NP
O	1286	1287	(	(	(	O
O	1287	1290	MEK	MEK	NN	B-NP
O	1290	1291	)	)	)	O
O	1292	1301	inhibitor	inhibitor	NN	B-NP
O	1301	1302	,	,	,	O
O	1303	1308	U0126	U0126	NN	B-NP
O	1308	1309	,	,	,	O
O	1310	1318	impaired	impair	VBD	B-VP
O	1319	1327	modestly	modestly	RB	B-ADVP
O	1328	1331	the	the	DT	B-NP
O	1332	1339	ability	ability	NN	I-NP
O	1340	1342	of	of	IN	B-PP
O	1343	1348	FVIIa	FVIIa	NN	B-NP
O	1349	1351	to	to	TO	B-VP
O	1352	1359	promote	promote	VB	I-VP
B-Cell	1360	1364	cell	cell	NN	B-NP
O	1365	1373	survival	survival	NN	I-NP
O	1373	1374	.	.	.	O

O	1375	1377	In	In	IN	B-PP
O	1378	1388	conclusion	conclusion	NN	B-NP
O	1388	1389	,	,	,	O
O	1390	1395	FVIIa	FVIIa	NN	B-NP
O	1396	1403	binding	binding	NN	I-NP
O	1404	1406	to	to	TO	B-PP
O	1407	1409	TF	TF	NN	B-NP
O	1410	1418	provided	provide	VBD	B-VP
O	1419	1429	protection	protection	NN	B-NP
O	1430	1437	against	against	IN	B-PP
O	1438	1447	apoptosis	apoptosis	NN	B-NP
O	1448	1455	induced	induce	VBN	B-VP
O	1456	1458	by	by	IN	B-PP
O	1459	1465	growth	growth	NN	B-NP
O	1466	1472	factor	factor	NN	I-NP
O	1473	1484	deprivation	deprivation	NN	I-NP
O	1484	1485	,	,	,	O
O	1486	1495	primarily	primarily	RB	B-ADVP
O	1496	1503	through	through	IN	B-PP
O	1504	1514	activation	activation	NN	B-NP
O	1515	1517	of	of	IN	B-PP
O	1518	1521	PI3	PI3	NN	B-NP
O	1521	1522	-	-	HYPH	B-NP
O	1522	1528	kinase	kinase	NN	I-NP
O	1528	1529	/	/	SYM	B-NP
O	1529	1532	Akt	Akt	NN	I-NP
O	1533	1540	pathway	pathway	NN	I-NP
O	1540	1541	,	,	,	O
O	1542	1545	and	and	CC	O
O	1546	1548	to	to	TO	B-PP
O	1549	1550	a	a	DT	B-NP
O	1551	1557	lesser	less	JJR	I-NP
O	1558	1564	extent	extent	NN	I-NP
O	1564	1565	,	,	,	O
O	1566	1569	p44	p44	NN	B-NP
O	1569	1570	/	/	SYM	O
O	1570	1572	42	42	CD	B-NP
O	1573	1577	MAPK	MAPK	NN	I-NP
O	1578	1585	pathway	pathway	NN	I-NP
O	1585	1586	.	.	.	O

